A M Coudray
Impact in
- Endocrine and Autonomic Systems top 10%
- Regulation of Appetite and Obesity
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 3
-
- Chemical Synthesis and Analysis 2
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- G Rosselin (5 shared papers)D. Bataille (4 shared papers)Viktor Mutt (3 shared papers)Christian Gespach (7 shared papers)M.E. Forgue-Lafitte (3 shared papers)B. Bréant (1 shared paper)Julien C. Marie (1 shared paper)Kazuhiko Tatemoto (1 shared paper)
In The Last Decade
A M Coudray
11 papers receiving 402 citations
Peers
Comparison fields: 5 of 68
- Endocrine and Autonomic Systems 73
- Endocrinology, Diabetes and Metabolism 165
- Cellular and Molecular Neuroscience 125
- Gastroenterology 26
- Surgery 111
Countries citing papers authored by A M Coudray
This map shows the geographic impact of A M Coudray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Coudray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Coudray more than expected).
Fields of papers citing papers by A M Coudray
This network shows the impact of papers produced by A M Coudray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Coudray. The network helps show where A M Coudray may publish in the future.
Co-authors
The 25 scholars most cited alongside A M Coudray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 140 | |
| 2 | 1981 | 70 | |
| 3 | 1981 | 68 | |
| 4 | Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. | 1989 | 58 |
| 5 | Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines. | 1992 | 21 |
| 6 | 2000 | 18 | |
| 7 | 1990 | 14 | |
| 8 | [Preclinical studies of oxaliplatin in combination chemotherapy]. | 2001 | 10 |
| 9 | 2005 | 9 | |
| 10 | 1996 | 3 | |
| 11 | Devazepide (L-364718) inhibits growth and increases expression of tumor markers in HT29-S-B6 cells. | 1996 | 1 |
| 12 | 1983 | 0 |
About A M Coudray
A M Coudray is a scholar working on Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Surgery, having authored 12 papers that have together received 412 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Chemical Synthesis and Analysis (2 papers), Diet, Metabolism, and Disease (2 papers), Diabetes Treatment and Management (2 papers), Estrogen and related hormone effects (1 paper), Glycosylation and Glycoproteins Research (1 paper), Ubiquitin and proteasome pathways (1 paper) and Microbial Metabolites in Food Biotechnology (1 paper). The work is most often cited by research in Endocrine and Autonomic Systems (73 citations), Endocrinology, Diabetes and Metabolism (165 citations), Cellular and Molecular Neuroscience (125 citations), Gastroenterology (26 citations) and Surgery (111 citations). A M Coudray has collaborated with scholars based in France and Sweden. Frequent co-authors include G Rosselin, D. Bataille, Viktor Mutt, Christian Gespach, M.E. Forgue-Lafitte, B. Bréant, Julien C. Marie, Kazuhiko Tatemoto, Ján Mešter and Dominique Fagot. Their work appears in journals such as International Journal of Oncology, FEBS Letters, Anti-Cancer Drugs, Peptides and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.